Quantification of Thrombocytes Number and Function in Patients Undergoing Prolonged Extracorporeal Circulation
NCT ID: NCT02771223
Last Updated: 2016-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2016-05-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices
NCT01481012
Thrombin in Cardiac Surgery
NCT04762576
Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution
NCT03326323
Management of Bleeding Following Cardiopulmonary Bypass
NCT00672516
Miniaturized Extracorporeal Circulation Study
NCT03216720
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Observational study on 20 patients undergoing prolonged ECC
* Blood sampling every 30 minutes for platelet count, platelet adhesion markers and coagulation studies
* Blood test to be performed in Rambam Blood Bank Laboratory
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
patients scheduled for prolonged cardiac surgery (over 3 hours anticipated ECC time) with no known coagulation disorders
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for prolonged cardiac surgery requiring ECC time over 3 hours
Exclusion Criteria
* antiplatelet therapy other then aspirin
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Amit Lehavi MD FANZCA
Director of Pediatric Anesthesia
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-645
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.